Download now the Official In-Person Agenda
Agenda for the Virtual Format of the conference
Please note: The agenda below is only for the virtual format.
1. Antibody Engineering & Therapeutics
2. Inhalation & Respiratory Drug Delivery
3. Pharmacovigilance & Drug Safety
4. Pre-filled Syringes & Injectables
5. Gut-Brain Axis
6. Probiotics, Human & Skin Microbiome
7. Aseptic Processing Technology
8. CDx/Biomarkers & Biobanking
Day 1
Day 2
Day 2 | 14:00
Stefan Zielonka, Associate Director at Merck KGaA
Day 1
Part I: The challenges of developing inhalation drugs
Day 2
Part III: New Approaches to Treating Respiratory Diseases
Part IV: New analytical insights into dry powder formulations for inhalation
Part II: Inhalation Formulation Solutions & Technology
Part V: New Approaches to Inhalation Product Development and Production
Day 1
Day 2
Day 1 | 10:00
Next generation design and materials for PFS
Day 1
Day 2
Day 2 | 12:00
Day 1
Day 2
Day 1
Biobanking (Part I)
Day 2
CDx & Biomarkers (Part II)
CDx & Biomarkers (Part I)
Biobanking (Part II)

